Claire O'Hanlon is a Ph.D. candidate at the Pardee RAND Graduate School and an assistant policy analyst at RAND. O'Hanlon was previously a research assistant at University of Chicago School of Medicine, where she worked on validating prognostic models of life expectancy in older patients with diabetes. During this time, O'Hanlon was also a business development intern at Knopp Biosciences, a biotechnology start-up, where she developed a pharmacoeconomic model and graphical user interface to calculate the progression and costs of Parkinson's disease under user-defined assumptions. O'Hanlon also worked as a laboratory technician at Duquesne University, where she designed MRI-visible delivery agents for water-insoluble drugs. O'Hanlon holds a master of public policy degree from the University of Chicago Harris School, a certificate in health administration and policy from the University of Chicago, and a B.S. in engineering from Harvey Mudd College. She studied abroad at the University of Auckland, New Zealand. Her interests include health policy, health care technology, and science and technology policy.
O'Hanlon CE, Amede KG, O'Hear MR, Janjic JM, "NIR-Labeled Perfluoropolyether Nanoemulsions for Drug Delivery and Imaging," Journal of Fluorine Chemistry, 137:27-33, 2012